Maker of cognitive training game seeks FDA approval
September 26, 2011//
Good brief article at New Scientist, Maker of cognitive training game seeks FDA approval:
- “Imagine walking away from a doctor’s office with a prescription to play a video game. Brain Plasticity, the developer of a cognitive training game, has begun talks with the Food and Drug Administration (FDA) to market the game as a therapeutic drug.”
- “Brain Plasticity has been fine-tuning a game to help people with schizophrenia improve the deficits in attention and memory that are often associated with the disorder.”
Posted in Technology & Innovation
1 Comments
About SharpBrains
SHARPBRAINS is an independent think-tank and consulting firm providing services at the frontier of applied neuroscience, health, leadership and innovation.
SHARPBRAINS es un think-tank y consultoría independiente proporcionando servicios para la neurociencia aplicada, salud, liderazgo e innovación.
Is there anything the FDA doesn’t think it needs to look at or control to go to market?